Key result
Angiopoietin-like proteins (ANGPTLs) regulate acute and chronic inflammation and are emerging as potential biomarkers and pharmacological targets for inflammatory diseases.
Why the study?
Understanding the emerging roles and mechanisms of angiopoietin-like proteins in acute and chronic inflammation may aid drug and therapy development.
This review highlights the emerging role of angiopoietin-like proteins in inflammation, suggesting they may serve as both biomarkers and therapeutic targets for inflammatory and cardiovascular diseases.
Answers are grounded in this paper and cite their sources.
ANGPTLs merit targeted investigation as inflammation biomarkers and therapeutic candidates in CVD; leaves open clinical utility pending prospective trials.
Angiopoietin-like proteins (ANGPTLs), a family of eight secreted glycoproteins termed ANGTPL1-8, are involved in angiogenesis, lipid metabolism, cancer progression, and inflammation. Their roles in regulating lipid metabolism have been intensively studied, as some ANGPTLs are promising pharmacological targets for hypertriglyceridemia and associated cardiovascular disease. Recently, the emerging roles of ANGPTLs in inflammation have attracted great attention. First, elevated levels of multiple circulating ANGPTLs in inflammatory diseases make them potential disease biomarkers. Second, multiple ANGPTLs regulate acute or chronic inflammation via various mechanisms, including triggering inflammatory signaling through their action as ligands for integrin or forming homo- /hetero-oligomers to regulate signal transduction via extra- or intracellular mechanisms. As dysregulation of the inflammatory response is a critical trigger in many diseases, understanding the roles of ANGPTLs in inflammation will aid in drug/therapy development. Here, we summarize the roles, mechanisms, and potential therapeutic values for ANGPTLs in inflammation and inflammatory diseases.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2021) conducted a review in Inflammation and inflammatory diseases. Angiopoietin-like proteins (ANGPTLs) was evaluated. Angiopoietin-like proteins (ANGPTLs) regulate acute and chronic inflammation and are emerging as potential biomarkers and pharmacological targets for inflammatory diseases.
Synapse has enriched 10 related papers. Consider them for comparative context: